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Purpose: To evaluate the positive predictive value (PPV) of bilateral whole-breast ultrasonography 
(BWBU) for detection of synchronous breast lesions on initial diagnosis of breast cancer and 
evaluate factors affecting the PPV of BWBU according to varying clinicoimaging factors.
Methods: A total of 75 patients who had synchronous lesions with pathologic confirmation at 
the initial diagnosis of breast cancer during January 2007 and December 2007 were included. 
The clinical factors of the patients were evaluated. One observer retrospectively reviewed the 
imaging studies of the index breast cancer lesion and the synchronous lesion. The PPV for 
additional biopsy was calculated for BWBU and various clinical and imaging factors affecting the 
PPV for BWBU were evaluated.
Results: The overall PPV for additional biopsy was 25.7% (18 of 70). The PPV for synchronous 
lesions detected both on mammography and BWBU, and detected only on BWBU, was 76.9% 
(10 of 13) and 14.3% (7 of 49), respectively. There was no clinical factor affecting the PPV for 
BWBU. Among the imaging factors, ipsilateral location of the synchronous lesion to the index 
lesion (P=0.06) showed a marginal statistically significant correlation with malignancy in the 
synchronous breast lesion. A mass with calcification on mammography presentation (P<0.01), 
presence of calcification among the ultrasonography findings (P<0.01), and high Breast Imaging 
Reporting and Data System final assessment (P<0.01) were imaging factors that were associated 
with malignancy in the additional synchronous lesion.
Conclusion: BWBU can detect additional synchronous malignancy at the diagnosis of breast 
cancer with a relatively high PPV, especially when mammography findings are correlated with 
ultrasonographic findings.
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Introduction
As a result of greater awareness of breast cancer by the physician and the patient with expansion 
PPV of additional breast lesions in whole breast US
e-ultrasonography.org Ultrasonography 33(3), July 2014 171
of breast cancer screening, more of these tumors are detected in 
the earlier stages [1]. Women who require surgical treatment of 
early stage breast cancer may prefer to undergo breast-conserving 
therapy, as oncologic breast surgery can have a profound impact on 
a woman’s body image and sense of self. Detection of synchronous 
breast cancers on initial diagnosis is critical for determining eligibility 
for breast conserving surgery [2]. 
Mammography is the only proven efficacious radiographic 
screening technique for detection of breast cancer; however, 
the sensitivity of mammography has been reported to be lower 
in women with dense breasts than in women with primarily 
fatty breasts (62.2% vs. 88.2%) [3,4]. Furthermore, detection 
of synchronous malignancy is more challenging because the 
additionally detected breast cancer lesions are known to be smaller 
and less suspicious than the index cancer [5]. Bilateral whole-
breast ultrasonography (BWBU) has been used to overcome these 
limitations of mammography and has been reported to be an 
efficacious imaging modality in identifying mammographically occult 
breast cancer in preoperative staging [6]. Hence, the roles of various 
other imaging modalities are under study for detection of breast 
cancer lesions not detected on mammography or clinical breast 
examination [7]. To our knowledge, there has been no published 
study regarding the positive predictive value (PPV) of BWBU in 
detection of synchronous breast lesions in a large population. 
The purpose of our study was to evaluate the PPV of BWBU 
on detection of synchronous breast lesions on initial diagnosis of 
breast cancer and also evaluate factors affecting the PPV of BWBU 
according to various clinical and imaging factors.
Materials and Methods
Our institutional review board approved this study and waived the 
informed consent requirement because this was a retrospective 
study.
Patients
Between January 2007 and December 2007, 694 women recently 
diagnosed with breast cancer at our institution (n=346) or another 
hospital (n=348) were reviewed in this study. All of the patients 
underwent mammography before BWBU. The patients with 
additional breast lesions with suspicious radiological findings other 
than the primary breast cancer lesion that underwent imaging-
guided biopsy or surgical resection after imaging-guided localization 
were reviewed in the study. 
Image Evaluation and Diagnostic Strategy for Additional 
Lesions
Mammograms were obtained with dedicated equipment, a Selenia 
Full-Field Digital Mammography System (Lorad/Hologic, Danbury, 
CT, USA). Standard craniocaudal and mediolateral oblique views 
were routinely obtained and additional mammographic views were 
obtained as needed. If recent mammograms taken from another 
hospital were available at the time of BWBU, routine mammograms 
were not performed in our institution.
BWBU was performed using ATL HDI 5000 and 3000 (Philips 
Medical Systems, Bothell, WA, USA) ultrasonography units with 
10-MHz linear array transducers by 5 full-time board-certified 
radiologists, all having at least several years of experience in 
performing breast ultrasonography (2-11 years). The radiologists 
performing BWBU knew the results of any mammograms and 
previous sonograms. Ultrasonography was performed with the 
patient in the supine position with the arms raised. If necessary, 
the patient was shifted into an appropriate contralateral posterior 
oblique position so that the lateral and inferior parts of the breasts 
could be scanned. Scanning was performed in the radial and 
antiradial planes, as well as in the longitudinal and transverse planes 
[8]. Scanning of both axillas started from the lower part of the axilla 
and continued upward toward the axillary fossa. The examination 
took approximately 15 minutes (range, 10 to 20 minutes). 
Al l  addit ional synchronous breast lesions detected on 
ultrasonography with a Breast Imaging Reporting and Data System 
(BI-RADS) category higher than 4 were sampled for biopsy with 
a ultrasonographic (US)-guided 14-gauge automatic core-needle 
biopsy (CNB). When there were two or more suspicious synchronous 
breast lesions, the most suspicious lesion or the lesion that could 
alter the surgical method was selected for biopsy. All additional 
synchronous breast lesions detected only on mammography as 
suspicious calcifications and not identified on ultrasonography were 
sampled for biopsy under mammography-guided localization. 
Retrospective Image Review and Data Analysis
We defined the index lesion as the mass that was either detected by 
the patient as a palpable lump, the mass that was first detected by 
imaging modalities such as mammography, or that was categorized 
as the highest final assessment by BI-RADS when two or more 
lesions were detected simultaneously in screening BWBU in a 
patient with dense breasts on a mammogram. A synchronous lesion 
was defined as a lesion that showed suspicious findings other 
than the index lesion detected in the same initial BWBU exam that 
appeared more than 2 cm from the index lesion.
Clinical information on the patients was collected by retrospective 
chart review. The age of the patient at diagnosis of breast cancer, 
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family history of breast cancer, and menopause status were 
reviewed. The mammographic and ultrasonographic images of 
the index and synchronous lesion were retrospectively reviewed 
by one radiologist (MJK). The index and synchronous lesions 
detected on mammography were described as a mass only, mass 
with calcification, or calcification only. For the ultrasonographic 
images, the size of each lesion was measured, and the locations of 
the synchronous additional lesions were categorized as ipsilateral 
or contralateral to the index lesion. All index and additional 
synchronous lesions were described according to the BI-RADS 
lexicon [9]. The BI-RADS final assessment given for the index lesion 
and the additional lesion according to the mammographic and 
ultrasonographic findings were based on the category classifications 
of the original radiology reports. 
The PPV was determined according to the clinicoradiologic 
features of the index and additional lesions. The Student t-test was 
used for comparison of continuous variables and the chi-squared 
test was used for categorical data. Logistic regression was used to 
construct a multivariate model of independent factors associated 
with the risk of additional synchronous breast lesions’ malignancy. 
Statistical significance was assigned to P-values less than 0.05. Data 
was analyzed using the SPSS ver. 12.0 (SPSS Inc., Chicago, IL, USA).
Results
Among the 694 patients diagnosed with breast cancer, 75 patients 
(10.8%) had 97 additional breast lesions that underwent further 
pathologic confirmation through US-guided CNB (n=70) and 
mammography-guided localization and excision biopsy (n=27). 
These 27 cases detected only on mammography were excluded from 
the data analysis. Among the 27 cases, three lesions (11.1%) were 
pathologically confirmed as malignant and 24 lesions (88.9%) as 
benign. Among 70 cases by US-guided core-needle biopsy in 54 
women, 18 lesions (25.7%) were diagnosed as malignant and 52 
lesions (74.3%) as benign; the overall PPV for additional biopsy 
was 25.7%. Among the 70 lesions, 13 lesions were seen in both 
US and mammography with a PPV for biopsy of 76.9% (10/13), 49 
(70%) were detected only in US with a PPV of 14.3% (7/49), and 
the remaining 8 lesions could not be correlated with mammography 
because there were no available mammograms (Fig. 1). Thirty-nine 
synchronous breast lesions were found ipsilateral to the index lesion 
and 31 lesions were found contralateral to the index lesion; the PPV 
for ipsilateral and contralateral lesions were 35.9% and 12.9%, 
respectively (Fig. 2).
Pathology of Synchronous Lesions According to the Clinical 
Factors of Patients
The 54 patients in the study ranged in age from 30 to 74 years. The 
patients with additional benign synchronous breast lesions had a 
mean age of 44.7 years (range, 30 to 74 years), and the patients 
with additional malignant synchronous breast lesions had a mean 
age of 45.4 years (range, 30 to 74 years) (Table 1). There was no 
statistical significance between the patients age and the PPV for 
additional synchronous malignant lesions (P=0.63). Six of the 54 
patients had a family history of breast cancer; 3 patients had a family 
history of their sisters with breast cancer, 2 patients in their mothers, 
14
97 Additional synchronous lesions
70 Additional synchronous lesions
13 US (+) & mammography (+) 49 US (+) & mammography (-)
24 Benign
3 Malignant
10 Malignant
(76.9%)
3 Benign
(23.0%)
7 Malignant
(14.3%)
42 Benign
(85.7%)
8 Lesions with no
available mammogram
27 Lesions detected by
mammography alone
Fig. 1. Diagram of pathologic diagnosis of 
synchronous lesions according to variable 
imaging modalities. US, ultrasonography.
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and 1 patient in her aunt. Two patients with a family history of 
breast cancer had additional synchronous malignant breast lesions; 
however, there was no statistical significance between a patient’s 
family history and the PPV for additional synchronous malignant 
lesions (P=0.79). Correlation between the menopause status of the 
patient and additional synchronous malignant lesions also did not 
show statistical significance (P=0.30).
Pathology of Synchronous Lesions According to the Imaging 
Factors of Index Lesions 
The imaging factors of 54 index lesions according to the pathology 
of 70 synchronous breast lesions did not show any imaging factor of 
the index lesion that correlated significantly with the pathology of a 
synchronous breast lesion (Table 2). 
Pathology of Synchronous Lesions According to the Location 
and Imaging Factors of Synchronous Lesions
With regard to the location of synchronous lesions to the index 
lesion, an ipsilateral location of a synchronous lesion showed 
marginal significance for correlating with a malignant pathology 
(P=0.06). Among the imaging factors of 70 synchronous breast 
lesions, a mass with calcification presented on mammography 
(P<0.01), the presence of calcification among the ultrasonographic 
findings (P<0.01), and a high BI-RADS final assessment (P<0.01) 
were imaging factors with statistical significance for the additional 
synchronous lesion to be malignant (Table 3). On multivariable 
logistic regression analysis, these factors showed statistical 
significance; a mass with calcification mammography presentation 
(odds ratio [OR], 2.95; 95% confidence interval [CI], 0.11 to 8.32), 
presence of calcification (OR, 3.36; 95% CI, 0.14 to 82.92), and 
higher BI-RADS assessment of the synchronous additional lesion 
(OR, 6.30; 95% CI, 0.70 to 55.01) were found to be statistically 
significant independent factors associated with malignancy of the 
synchronous lesion.
Discussion
Breast conservation therapy is the preferred method of treatment 
for women with stage I or II breast cancer instead of mastectomy 
and conservation surgery with radiation therapy [10]. Holland et al. 
[11] found a total of 43% (121 out of 282) additional tumor foci in 
mastectomy specimens more than 2 cm away from the index cancer. 
70 Additional synchronous lesions
39 Ipsilateral breast lesions 31 Contralateral breast lesions
14 Malignant
(35.9%)
25 Benign
(64.1%)
4 Malignant
(12.9%)
27 Benign
(87.1%)
Fig. 2. Diagram of pathologic diagnosis of 
additional synchronous lesions according 
to the location of the index lesion.
Table 1. Clinical factors of 54 patients with synchronous lesions by bilateral whole-breast ultrasonography
Clinical factor
Histopathologic outcome
Additional synchronous benign breast lesion 
(n=38)
Additional synchronous malignant breast lesion 
(n=16)
P-value
Age (yr), mean±SD (range) 44.7±9.10 (30-74) 45.4±9.97 (30-74) 0.63
Family history of breast cancer 4 4 0.79
Menopause 0.30
    Premenopause 30 11
    Menopause 5 5
    Unknown 3 3
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Table 2. Pathology of synchronous lesions according to imaging 
factors of 54 index lesions
Characteristic
Histopathologic outcome
Benign a)(n=52) Malignant b)(n=18) P-value
Size (mm), 
    mean±SD (range)
20±9.8 (4-40) 17±9.5 (5-41) 0.23
Mammography presentation c) 0.46
 Negative 8 1
 Mass only 24 8
 Mass with 
 microcalcifications
11 5
 Calcifications only 1 2
 Not available 7 1
Ultrasonogrphic findings
    Shape c) 0.93
 Round 6 3
 Oval 13 4
 Irregular 31 10
Orientation 0.84
 Parallel 14 5
 Non-parallel 36 12
Margin 0.17
 Well-circumscribed 4 4
 Indistinct 4 3
 Angular 7 0
 Microlobulated 20 5
 Spiculated 15 5
Boundary 0.42
 Abrupt 31 13
 Echogenic halo 19 4
Echogenicity 0.44
 Anechoic 0 0
 Hyperechoic 2 1
 Complex 0 0
 Hypoechoic 36 12
 Isoechoic 12 4
Acoustic attenuation 0.87
 None 38 12
 Enhancement 8 3
 Shadowing 4 2
Calcification 0.39
 None 20 6
 With calcification 30 11
Final assessment 0.63
 Category 4a 6 2
 Category 4b 10 2
 Category 4c 15 3
 Category 5 19 10
a) Additional synchronous benign breast lesion. b) Additional synchronous malignant 
breast lesion. c) Imaging features of 3 index breast lesions were not included 
because they were previously excised (2 in additional benign and one in additional 
malignant). 
Table 3. Pathology of synchronous lesions according to location 
and imaging factors of 70 additional breast lesions seen on 
ultrasonography 
Characteristic
Histopathologic outcome
Benign a)(n=52) Malignant b)(n=18) P-value
Size (mm), 
    mean±SD (range)
7.8±3.9 (4-21) 8.7±3.8 (4-17) 0.36
Location related to index lesion 0.06
 Ipsilateral 25 14
 Contralateral 27 4
Mammography presentation <0.01
 Negative 42 7
 Mass only 1 1
 Mass with 
 microcalcifications
0 5
 Calcifications only 2 4
 Not available 7 1
Ultrasonographic findings 13 4
    Shape 0.22
 Round 12 8
 Oval 23 6
 Irregular 17 4
Orientation 0.32
 Parallel 32 8
 Non-parallel 20 10
Margin 0.53
 Well-circumscribed 4 1
 Indistinct 12 4
 Angular 7 0
 Microlobulated 23 10
 Spiculated 6 3
Boundary 0.40
 Abrupt 47 18
 Echogenic halo 5 0
Echogenicity 0.82
 Anechoic 0 0
 Hyperechoic 1 0
 Complex 0 0
 Hypoechoic 27 9
 Isoechoic 24 9
Acoustic attenuation 0.53
 None 48 18
 Enhancement 4 0
 Shadowing 0 0
Calcification <0.01
 None 50 10
 With calcification 2 8
Final assessment <0.01
 Category 4a 46 9
 Category 4b 4 2
 Category 4c 2 6
 Category 5 0 1
a) Additional synchronous benign breast lesion. b) Additional synchronous malignant 
breast lesion.
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Moreover, contralateral synchronous breast cancers are known to 
lower the survival rate compared to unilateral breast cancer [12,13]. 
Therefore, the exact characterization of synchronous lesions other 
than the primary cancer lesion at the time of initial diagnosis is 
crucial for surgical planning as well as establishing the prognosis 
of the patient [2]. Although mammography is the only proven 
efficacious radiographic screening technique for detection of breast 
cancer, whole breast ultrasonography is considered an adjunct 
to mammography in the preoperative staging of breast cancer 
[13]. Buchberger et al. [14] verified the role of ultrasonography in 
detection of mammographically and clinically occult carcinoma with 
28 malignant lesions only found on ultrasonography among a total 
of 103 malignancies. The purpose of this study was to evaluate 
the role of ultrasonography in the preoperative staging of patients 
with breast cancer in identifying any synchronous breast lesions for 
accurate breast cancer staging and optimize treatment planning. 
Our results show the overall PPV of biopsies for additional 
synchronous lesions in patients with breast cancer on BWBU to 
be 25.7% regardless of mammographic findings and the PPV for 
lesions detected only on ultrasonography to be 14.3%. These results 
are lower than previously reported PPV values of 30%-40% for 
ultrasonographic screening in high-risk patients [14,15]. These 
results could be explained by the fact that each subtle but suspicious 
lesion (70 lesions in 54 patients) identified in preoperative 
ultrasonography for breast cancer needed to be confirmed by 
biopsy, and we might lower the threshold of the category for lesions 
because we were already aware that about 11.4% additional breast 
lesions in breast cancer patients show malignancy more frequently 
than expected, even though they appear to be probably benign, 
through our own experience and the literature [2]. Meticulous 
evaluation of the remaining breast lesions was inevitable, and any 
subtle but suspicious findings lead the radiologist to consider the 
lesion to be a suspicious finding and perform biopsy for pathologic 
confirmation with the long-term experience of preoperative 
ultrasonography. This could have played a role lowering the PPV, 
compared with the results of other studies with high risk patients 
[7]. The PPV according to the final assessment was 16.4% (9/55), 
33.3% (2/6), 75.0% (6/8), and 100.0% (1/1) for categories 4a, 4b, 
4c, and 5 lesions, which is consistent with a previous report based 
on ultrasonographic findings [16], which still means that the BI-
RADS category can predict malignancy for the synchronous breast 
lesions in patients with breast cancer. However, we did not reclassify 
the ultrasonographic findings of additional nodules to check how 
many cases would have undergone biopsy or follow-up among 
patients who had undergone routine screening.
The clinical factors of the patients did not show statistical 
significance in detection of additional synchronous malignancy in 
patients with breast cancer. The age of the patient, family history 
of breast cancer, and menopause status were evaluated as clinical 
factors. Advanced age of the patient, family history of breast cancer, 
and natural menopause after age 45 are well known risk factors of 
breast cancer [17]. However, our results showed that these clinical 
risk factors were not related to an additional synchronous breast 
cancer lesion; as our study population is small, further investigation 
with a larger population is needed.
The relationship of a synchronous lesion to its index lesion was 
evaluated, and an ipsilateral location of the synchronous lesion 
showed marginal statistical significance for detection of additional 
synchronous malignancy. Previous studies also showed a higher 
PPV for additional lesions in an ipsilateral location [2]; therefore, 
the threshold for category 4 should be set more sensitive than for 
patients at a normal risk level when additional lesions are found 
ipsilaterally to the index lesion. In this study, none of the other 
imaging findings of the index lesion helped suggest malignancy of 
the synchronous lesion, and thorough inspection of the synchronous 
lesion itself is most important. 
The PPV of biopsy for additional synchronous lesions detected 
both on mammography and ultrasonography (76.9%) was much 
higher than that detected only on ultrasonography (14.3%). At 
our institution, ultrasonography is performed just after review 
of the mammogram, which are interpreted together because 
missed cancers on the mammogram have been well known to 
be detected in about half of cases during retrospective review 
[18]. Even if the radiologist who reviews a mammogram does not 
find any abnormality prospectively, the radiologist might have 
searched for any subtle abnormality on the mammogram when a 
ultrasonographic lesion was detected, and then the abnormality 
could be mentioned. Only in cases showing no abnormality on 
the mammogram even during retrospective review, was the 
mammogram diagnosed as negative. Likewise, careful inspection 
of the area where an abnormality was detected on mammography 
was conducted on ultrasonography by the operator. Such a situation 
may have resulted in a relatively low incidence and low PPV of 
mammographically occult synchronous cancers detected only on 
ultrasonography.
Our study results showed that the PPV for additional lesions seen 
only on ultrasonography (14.3%) was higher than that of lesions 
detected only on mammography (11.1%), although statistical 
evaluation for significance was not performed and the analysis for 
the cases detected only on mammography was excluded in this 
study (Fig. 1). The PPV for lesions detected on mammography was 
lower than the Bi-RADS recommendation rate of 20%. These lesions 
correspond to synchronous additional lesions seen as calcifications 
on mammography but not detected on ultrasonography and a 
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similar lower PPV has been reported previously for lesions only 
seen on mammography as calcifications [13]. The PPV for lesions 
detected only on ultrasonography also did not meet the biopsy 
recommendation rate by BI-RADS, and the large number of category 
4a lesions with only subtle findings could have been attributed to 
these results. The PPV of 14.3% for additional lesions seen only 
on ultrasonography, although the threshold for category 4 was set 
sensitively since the operator was aware of the index cancer, suggest 
preoperative BWBU to be a clinically significant imaging modality 
additional to mammography for detection of additional lesions in 
breast cancer patients.
Magnetic resonance imaging (MRI) can be another adjunct 
imaging modality in detection of additional synchronous malignancy 
in patients with breast cancer. An annual MRI is recommended in 
addition to mammography to women at very high risk of breast 
cancer in the United States with a high sensitivity in detection of 
malignancy [19,20]. However, only a limited number of patients 
actually underwent breast MRI in our study, and the high cost, 
requirement of contrast injection, and limited availability were the 
main reasons why MRI is not a well-established imaging modality. 
Further study is needed for evaluation of the role of MRI in detection 
of additional synchronous malignancy in patients with breast cancer, 
and the role of BWBU and MRI should be compared in order to use 
these imaging modalities as a screening tool in patients with breast 
cancer. 
There were some limitations to our study. First, our study 
population with additional breast lesions that were pathologically 
confirmed in newly diagnosed breast cancer patients was small. 
Second, the study was conducted at a single site with only a limited 
number of radiologists and included mainly Asian women. Third, 
the clinical and imaging factors were only evaluated with respect 
to synchronous lesions detected on ultrasonography. Other imaging 
modalities such as mammography and MRI were not evaluated 
according to clinical and imaging factors. Furthermore, the negative 
predictive value was not evaluated. Furthermore, we did not 
suggest a standard for category 4 lesions to prevent unnecessary 
biopsies. In addition, the mammography was reviewed prior to the 
performance of US, which can affect the results of BWBU. Finally, the 
mammographic findings of synchronous lesions were retrospectively 
reviewed with the information of BWBU, which can also affect the 
mammographic interpretation of synchronous lesions.
In conclusion, BWBU can detect additional synchronous 
malignancy at the diagnosis of breast cancer with a relatively high 
PPV, especially when mammography findings are correlated with 
ultrasonographic findings.
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